Determination of multipurpose prevention technology choice for contraception and HIV/STI prevention: A survey of sexually active women in Nigeria

Author:

Ilomuanya Margaret O.1,Joda Arinola Eniola2,Adeyemi Oluwatosin Caleb3,Akapo Abiodun S.1,Ilomuanya Chinonyelum S.4,Ogwa Oluwafunmike5

Affiliation:

1. Department of Pharmaceutics and Pharmaceutical Technology, University of Lagos, Lagos State, Nigeria,

2. Department of Clinical Pharmacy and Biopharmacy, University of Lagos, Lagos State, Nigeria,

3. Department of Clinical Pharmacy and Biopharmacy, Drug Information Centre, University of Lagos, Lagos State, Nigeria,

4. Department of Medicine and Surgery, Bowen University, Iwo, Osun State, Nigeria,

5. Department of Community Medicine, University of Lagos, Lagos State, Nigeria,

Abstract

Objectives: Interest in human immunodeficiency virus (HIV) prophylaxis in the context of multiple sexual and reproductive health risks women face suggests a place for multipurpose prevention techniques (MPTs), which act by combining contraception and pre-exposure prophylaxis against HIV into one unified delivery method. At present, condoms are a readily available form of MPTs. The study aims to determine the sexual characteristics of women in Nigeria and assess factors associated with MPT acceptance in the identified population. Materials and Methods: An online cross-sectional survey was conducted using the data collection tool Google Forms®. The survey was distributed to the prospective respondents using the snowballing technique through an instant messaging application to ensure proper circulation among the geopolitical zones in Nigeria. Interest in MPT’s was evaluated using descriptive analysis. Specifically, personal and product attributes were evaluated descriptively (frequency and response rating) and with inferential statistics (logistic regression and model validation). Results: More than one-half (57%) of the participants were sexually active in the past three months. Most of the subjects reported at least one HIV risk behavior such as engaging in sexual intercourse with a male partner without a condom (50%). Factors associated with acceptance of MPTs included perceived safety, long-lasting action, and effectiveness of the formulation. Formulation types preferred by respondents include daily pills (21%), vaginal gels (12%), and inserts (8%). Personal characteristics supporting MPT use include age (30–39) and (40–49) years, married, formally educated, being a housewife, and having not had sexual intercourse with an HIV-positive male partner and having had an unintended pregnancy. Conclusion: Most of the respondents were interested in MPTs as a daily pill. Safety, long-lasting activity, and effectiveness are the top three criteria predicting acceptance. A variety of MPTs are required to be developed to suit the varying needs of different populations. The MPT preferences must be considered during product development to promote future acceptance among women in Nigeria.

Publisher

Scientific Scholar

Reference35 articles.

1. Shifts in intended and unintended pregnancies in the United States, 2001-2008;Finer;Am J Public Health,2014

2. Available from: http://apps.who.int/iris/bitstream/10665/75181/1/9789241503839_eng.pdf?ua=12012 [Last accessed on 2023 Dec 20]

3. We are not the same": African women's view of multipurpose prevention products in the TRIO clinical study;Shapley-Quinn;Int J Womens Health,2019

4. Multipurpose prevention technologies for sexual and reproductive health: Mapping global needs for introduction of new preventive products;Schelar;Contraception,2016

5. Male and female condoms: Their key role in pregnancy and STI/HIV prevention;Beksinska;Best Pract Res Clin Obst Gynaecol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3